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Introduction
Reduced saliva secretion and altered salivary composition are 
associated with xerostomia, that is, a subjective dry mouth feel, 
which seriously decreases the quality of patient life. Sjögren 
syndrome (von Bültzingslöwen et al. 2007; Castro et al. 2013), 
head and neck radiation therapy (Jellema et al. 2007), and use 
of medication (Tan et al. 2018) cause xerostomia (dry mouth). 
Glycoproteins, that is, mucins (Coles et al. 2010) in salivary 
condition films (SCFs), retain water and yield unmatchable 
hydration lubrication on the oral surface (Lee and Spencer 
2008). However, the aberrant SCFs of xerostomia patients with 
limited mucins attributed to the changed salivary composition 
and low salivary flow rate yield poor lubrication associated 
with dental erosion and dental caries (Liu et al. 2018). To mel-
low the symptoms, xerostomia patients use saliva substitutes, 
which contain either food-grade thickeners extracted from ani-
mal and plant sources or lubricant molecules like porcine gas-
tric mucins (PGMs), often masking and overwhelming the 
native SCFs. A Cochrane collaboration (Furness et al. 2011), in 
which 1,597 patients were included, concluded that topical 
delivery of saliva substitutes is ineffective in relieving dry 
mouth symptoms, which is also confirmed by Vinke et al. with 
the help of a tongue-enamel friction model (Vinke et al. 2018, 
2019).
In an actual dry oral cavity with limited saliva, endogenous 
glycoproteins, including mucins, are available and could 
potentially be used as a part of treatment instead of being dis-
regarded. Thus, an alternate strategy could be where instead of 
overwhelming the dry oral cavity with exogenous molecules, 
we work together and make mucins part of the solution. 
Intrigued by the fact that cationic polyelectrolytes (Salomaki 
and Kankare 2009) can improve the mechanical strength of 
polysaccharide multilayers, we tested their ability to act as an 
additive to improve oral lubrication by enhancing the SCFs. 
Chitosan (Kim et al. 2013, 2015) is a nature-derived cationic 
mucoadhesive with strong electrostatic interactions and a large 
amount of hydrogen bonding (Neto et al. 2014), especially 
after being modified with catechol (Chi-C), which endows it 
with water solubility at a neutral pH (Kim et al. 2015). Chi-C 
shows a high affinity to glycoprotein, and its oxidized deriva-
tive can bioconjugate with amines and cysteine residues of 
protein or glycoprotein through Michael addition or Schiff 
bases formation (Mizrahi et al. 2013; Yang et al. 2014; Neto 
et al. 2016; Ye et al. 2016), while its potential to stabilize SCF 
has never been investigated. We hypothesize that Chi-C will 
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Abstract
Oral lubrication mediated by mucin and protein containing salivary conditioning films (SCFs) with strong water retainability can get 
impaired due to disease such as xerostomia, that is, a subjective dry mouth feel associated with the changed salivary composition 
and low salivary flow rate. Aberrant SCFs in xerostomia patient cause difficulties in speech, mastication, and dental erosion while the 
prescribed artificial saliva is inadequate to solve the complications on a lasting basis. With the growing aging population, it is urgently 
needed to propose a new strategy to restore oral lubrication. Existing saliva substitutes often overwhelm the aberrant SCFs, generating 
inadequate relief. Here we demonstrated that the function of aberrant SCFs in a patient with Sjögren syndrome can be boosted 
through mucin recruitment by a simple mucoadhesive, chitosan-catechol (Chi-C). Chi-C with different conjugation degrees (Chi-C7.6%, 
Chi-C14.5%, Chi-C22.4%) was obtained by carbodiimide chemistry, which induced a layered structure composed of a rigid bottom and a 
soft secondary SCF (S-SCF) after reflow of saliva. The higher conjugation degree of Chi-C generates a higher glycosylated S-SCF by 
mucin recruitment and a lower friction in vitro. The layered S-SCF extends the “relief period” for Sjögren patient saliva over 7-fold, 
measured on an ex vivo tongue-enamel friction system. Besides lubrication, Chi-C-treated S-SCF reduces dental erosion depths from 
125 to 70 μm. Chi-C shows antimicrobial activity against Streptococcus mutans. This research provides a new key insight in restoring the 
functionality of conditioning film at articulating tissues in living systems.
Keywords: oral lubrication enhancement, mucin, dry mouth, Sjögren syndrome, conditioning film, chitosan-catechol
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bind to and absorb on the limited SCF; meanwhile, sessile Chi-C 
then attracts and recruits glycoproteins from saliva through 
electrostatic attraction and chemical binding to boost SCFs, 
which can enhance oral lubrication and resist dental erosion.
Here we tested the above hypothesis based on Chi-C with 
increasing conjugation degree (Chi-C7.6%, Chi-C14.5%, Chi-
C22.4%). The kinetics of SCF formation, the modification with 
Chi-C, and the formation of secondary SCF (S-SCF) during 
reflow of saliva were monitored by quartz crystal microbal-
ance with dissipation (QCM-D). The composition alteration in 
SCFs was determined by X-ray photoelectron spectroscopy 
(XPS). Lubrication properties of S-SCF with Chi-C treatment 
at the nanoscale were investigated by colloidal probe atomic 
force microscopy (AFM), and saliva from a patient with 
Sjögren syndrome who had Chi-C treatment was evaluated on 
an ex vivo tongue-enamel friction system (Vinke et al. 2018) at 
the macroscale. The antimicrobial efficacy of Chi-C and the 
ability of Chi-C-treated S-SCF to resist dental erosion were 
also tested.
Materials and Methods
Chi-C Synthesis, Formation of SCF, Chi-C Treatment 
of SCF, Formation of S-SCF, Change in SCF 
Composition, and Lubrication at the Nanoscale
Chi-C was synthesized using carbodiimide chemistry (Kim et 
al. 2013; Wang, Song, et al. 2017; Wang, Li, et al. 2017) and 
details are presented in the Appendix. A standard protocol 
(Veeregowda et al. 2012) was followed to collect and prepare 
stimulated whole saliva (SWS) from both healthy and patient 
volunteers. SWS from 4 healthy individuals (healthy saliva 
[HS]) and 4 patients (patient saliva [PS]) with Sjögren syn-
drome was collected for tongue-enamel friction measurement. 
All saliva collection and use were performed under the 
approval of the Medical Ethics Review Board of the University 
Medical Center Groningen (approval numbers M17.217043, 
M09.069162, M17.2157256, and UMCG IRB #2008109). A 
QCM-D device (E-4; Q-sense) was used to study the structural 
softness and formation kinetics of SCFs in vitro with or with-
out Chi-C treatment. Briefly, saliva was allowed to flow over a 
cleaned QCM-D sensor with 50 µL/min at 25°C for 2 h, corre-
sponding with a shear rate of 3 s−1, followed by perfusion with 
buffer or 0.05% w/v of Chi-C for 2 min, and finally saliva was 
allowed to reflow for another 2 h to form a secondary SCF 
(S-SCF). In between each step, the chamber was perfused with 
buffer for 15 min to remove unattached molecules from the 
tubes, chamber, and crystal surface. The crystals coated by a 
S-SCF with or without Chi-C treatment were taken out of the 
QCM-D for surface composition analysis by X-ray photoelec-
tron spectroscopy (details in the Appendix) and nano-lubricity 
evaluation by colloidal probe AFM (details in the Appendix).
Tongue-Enamel Friction System
The friction measurements at macroscale were performed in a 
reciprocating sliding between the tongue and enamel using the 
same protocol as Vinke et al. (2018) with a universal mechani-
cal tester (UMT-3; CETR, Inc.) under a normal force of 0.25 N 
at a sliding velocity of 4 mm/s and sliding distance of 20 mm. 
The ratio of measured friction force and applied normal force 
was taken as the coefficient of friction (COF).
First, the enamel was slid against the tongue for 10 cycles to 
obtain dry baseline and mimic dry mouth (Vinke et al. 2018). 
Then, a drop of 20 µL SWS from healthy controls or patients 
with Sjögren syndrome was placed at the tongue-enamel inter-
face and rubbed for 4 cycles to spread the saliva on the tongue 
surface and form the SCF, followed by another 20 µL of buffer 
or Chi-C22.4% and 4 cycles of rubbing (step 3). Finally, another 
20 µL of healthy or patient SWS was added to form the S-SCFs 
and the sliding was continued. The ratio between COF mea-
sured in dry baseline and wet S-SCFs was designated as 
“relief” using equation (1). The duration for which the COF 
remained low was designated as the “relief period.”
                         Relief = COF /COFdry wet  (1)
Dental Erosion Protection and Antimicrobial  
and Biocompatibility of Chi-C
Dental erosion was tested using an established protocol (Jager 
et al. 2008, 2012) on the bovine incisors, and the detailed pro-
tocol is presented in the Appendix. The antimicrobial efficacy 
of Chi-C was tested on Streptococcus mutans, and safety of 
Chi-C-treated S-SCF use was tested using the mouse fibroblas-
tic cell line (L929) and human kidney epithelial cells with the 
help of the XTT assay (Zhou et al. 2017) and microscopic 
examination of the cells. The protocols are described in detail 
in the Appendix.
Statistical Analysis
All data are expressed as mean ± SD. Statistical differences 
between groups were determined with a 2-tailed Student’s t 
test, with significance set at P < 0.05.
Results
Preparation and Characterization of Chi-C
Chi-C with 3 conjugation degrees was successfully synthe-
sized and respectively called Chi-C7.6%, Chi-C14.5%, and Chi-
C22.4%. H-NMR (nuclear magnetic resonance) and UV-Vis 
spectrophotometry helped prove conjugation (Appendix Fig. 
1) and calculation of the conjugation degree; detailed protocol 
and results are described in the Appendix.
In Vitro Modification of the SCF Due to Chi-C
After 2 h of salivary flow on the bare QCM-D sensor, a large 
amount of salivary protein adsorption took place, as shown by 
a large frequency shift (∆f3) of −70 ± 10 Hz and a dissipation 
(∆D3) greater than 10
–5 (Fig. 1). Exposure of SCF to buffer 
(Fig. 1A) yielded a small change in ∆f3 and ∆D3, while 
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exposure to Chi-C solutions (0.5 mg/mL) with 3 
conjugation degrees provided a significant 
increase in ∆f3 (Fig. 1E) and a decrease in ∆D3/∆f3 
(Fig. 1B–D) (dotted bars in Fig. 1F), suggesting a 
Chi-C-induced compaction of the SCF with hydro-
gen bonding, electrostatic attraction, and covalent 
bonding irrespective of the conjugation degree. To 
mimic the oral situation, saliva was reintroduced 
in the QCM-D, which caused renewed adsorption 
of salivary proteins and the formation of S-SCF 
(Fig. 1A–D). The higher conjugate degree of Chi-
C14.5% (–160 ± 15 Hz) and Chi-C22.4% (–170 ± 
8.6 Hz) led to larger frequency shifts and higher 
∆D3/∆f3 (striped bars in Fig. 1F) as compared to 
Chi-C7.6% (–130 ± 10 Hz) and buffer (–75 ± 10 Hz) 
exposure.
In Vitro Changes in Topography, 
Lubrication, and Composition of S-SCFs 
Induced by Chi-C
Salivary protein adsorption was also evident from 
the morphology of the S-SCFs as investigated by 
AFM and shown in Figure 2A. Bare sensor shows 
a smooth surface, but uneven, globular structures 
appeared after the adsorption of salivary protein 
with heights of about 23 ± 4 nm. Numerous similar 
30 ± 7 nm high structures were observed in S-SCF 
with Chi-C7.6%, 38 ± 5 nm in S-SCF with Chi-
C14.5%, and 37 ± 7 nm in S-SCF with Chi-C22.4%. 
Mucins in the SCFs are believed to be adsorbed in 
the form of loops and trains on the surface (Coles 
et al. 2010), and higher globular structures were 
found in S-SCFs with Chi-C, especially in Chi-
C22.4% and Chi-C14.5%, which could be caused by a 
large amount of mucin recruitment on the top layer.
Mucin recruitment was confirmed by the 
increased glycosylation of the S-SCFs with differ-
ent Chi-C treatment (Fig. 2B, Appendix Fig. 3, Table, Appendix 
Table 1) measured using X-ray photoelectron spectroscopy. 
The result from the Table showed a different relative content of 
C, O, N. The C1s spectra of each surface could be deconvoluted 
into 4 different peaks: C-(C,H), C-N/C-O, and O-C-O/ O=C-O, 
and their percentages for S-SCF with or without Chi-C treat-
ment were different, as shown in Appendix Figure 3 and the 
Table, suggesting different proteins were present on the sur-
face. In S-SCF with Chi-C treatment, the relative content of 
C-C was slightly decreased while the C-N was increased in the 
Table, which may be attributed to the protein or glycoprotein 
recruited to the surface. As for the O1s spectra, they could be 
deconvoluted into 2 components: O=C-N and O=C-O, consid-
ered the O from the protein and glycol group, respectively. The 
relative contents of glycoprotein could be calculated by the 
integral of O1s at 532.7ev in Figure 2B and Appendix Figure 2. 
The higher amount of O1s at 532.7ev (Veeregowda et al. 2012), 
that is, about 9.88 ± 1.6 and 9.35 ± 1.3, was achieved in SCF 
with Chi-C22.4% and Chi-C14.5% modification, respectively, 
while only 5.39 ± 2.25 and 7.04 ± 2.6 were detected in SCF 
with buffer and Chi-C7.6% treatment, respectively. This indi-
cates that Chi-C can recruit glycoprotein on the SCF surface to 
increase the glycosylation, which is in agreement with the 
higher ∆D3/∆f3 measured by QCM-D (Fig. 1F). The QCM-D 
crystals with S-SCFs were mounted under the colloidal probe 
AFM for lubrication evaluation. On the bare gold (Au), Ff 
increased linearly with Fn, corresponding to a COF of 0.25 ± 
0.03 (Fig. 2C, D), which is consistent with the literature 
(Veeregowda et al. 2013). Formation of S-SCF with an inter-
mediate exposure to buffer deceased the COF to 0.132 ± 0.021 
(Fig. 2C, D). S-SCFs with intermediate exposure to Chi-C fur-
ther decreased the COF to 0.053 ± 0.0052 with Chi-C7.6% and 
to 0.051 ± 0.0053 with Chi-C14.5%, and the extremely low COF 
was observed on S-SCFs with intermediate exposure to 
Figure 1. Kinetics of salivary conditioning film (SCF) formation, chitosan-catechol 
(Chi-C) adsorption to SCF, and renewed exposure to saliva to get S-SCF using the 
quartz crystal microbalance with dissipation (QCM-D). The mass adsorption was 
quantified by frequency shift and structural softness by calculating the ratio between 
dissipation and frequency shift. SCF treated with buffer (A), Chi-C7.6% (B), Chi-C14.5% 
(C), and Chi-C22.4% (D), respectively. (E) Frequency shift after renewed exposure to 
saliva and (F) structural softness of SCF with and without (buffer) Chi-C adsorption 
and renewed exposure to saliva. Error bar represents the standard deviation over 3 
independent measurements. *Statistically significant (P < 0.05, 2-tailed Student’s t test) 
differences in softness and frequency compared to control film. #Significant differences 
in frequency or softness of S-SCF with Chi-C22.4% treatment compared to S-SCF with 
Chi-C7.6% treatment. 
&Significant difference in frequency between S-SCF with Chi-C14.5% 
and Chi-C22.4% treatment.
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Chi-C22.4%, about 0.047 ± 0.0031. A clear correlation between 
the increasing structural softness and decreasing COF was 
obtained (Fig. 2E). A plateau with respect to COF was achieved 
with Chi-C22.4%, indicating that any further increase in the con-
jugation degree would probably not provide any further 
decrease in friction. The lowest COF was detected for S-SCF 
with Chi-C22.4% treatment, corresponding to the highest mass 
adsorption (Fig. 1E), highest structural softness (Fig. 1F), and 
highest glycosylation (Fig. 2D). Since Chi-C caused rigidifica-
tion (Fig. 1F) of the lower layer (SCF) irrespective of the Chi-C 
conjugation degree, the decrease in friction can be mainly 
attributed to increased softness of the top layer (S-SCF) due to 
mucin recruitment.
Translation of an In Vitro Observation  
to the Ex Vivo Stage and for Patient Saliva
Chi-C22.4% was chosen to explore its potential lubrication 
enhancement efficacy with saliva from patients with Sjögren 
syndrome (an etiology of xerostomia) on the tongue-enamel 
system (Vinke et al. 2018; Vinke et al., unpublished data) using 
real biological tissue, which can provide information for relief 
and relief period. Consistent with the observations in previous 
studies, a COFdry of around 2.5 was observed (Fig. 3). A sharp 
drop in COF was observed after formation of initial SCF with 
an introduction of 20 µL saliva (called COFwet). From Figure 
3C and D (black up arrow), a slight increase in COFwet is 
Figure 2. Secondary salivary conditioning film (S-SCF) change in composition, measured using X-ray photoelectron spectroscopy (XPS), in 
topography and nanofriction, measured by atomic force microscopy (AFM) and colloidal probe. (A) Surface topography of bare Au-coated crystal and 
S-SCF treated with buffer, Chi-C7.6%, Chi-C14.5%, and Chi-C22.4%, respectively. (B) The amount of glycoprotein (%O) in S-SCF with buffer or different 
conjugate degree Chi-C treatment was obtained from decomposition of O1s photoelectron peak in XPS. (C) Friction force versus applied load curves 
of bare quartz crystal microbalance with dissipation (QCM-D) crystal and S-SCF treated with buffer or Chi-C, respectively. (D) Coefficient of friction 
(COF) of each S-SCF calculated by slope of the linear fitting. (E) Correlation between structural softness of S-SCF and COF, and the higher structural 
softness of S-SCF the lower COF of S-SCF in vitro with colloidal probe AFM was achieved. *Statistically significant differences (P < 0.05) in the content 
of glycoprotein in S-SCF with Chi-C treatment with respect to S-SCF with buffer treatment in (B), or in COF between S-SCF and bare crystal in (D). 
#Statistically significant (P < 0.05) difference in COF of S-SCF treated with Chi-C respect to S-SCF treated with buffer. &Significant difference in COF 
between S-SCF with Chi-C22.4.% and Chi-C7.6% treatment, respectively. Chi-C, chitosan-catechol.
Table. Surfaces Chemical Bonding of S-SCF with or without (PBS) Chi-C Treatment.
C1s Binding Energy and Relative Area (%) O1s Binding Energy and Relative Area (%)
Samples C-C C-N O-C-O O-C=O N-C=O O=C-O
S-SCF-PBS 61.6 22.4 12.3 3.7 66.3 33.7
S-SCF-Chi-C7.6% 52.2 30.2 14.9 2.7 49.9 50.1
S-SCF-Chi-C14.5% 56.3 27.5 13.8 2.4 48.7 51.3
S-SCF-Chi-C22.4% 58.5 30.5 7.7 3.3 43.3 56.7
Chi-C, chitosan-catechol; PBS, phosphate-buffered saline; S-SCF, secondary salivary conditioning film.
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clearly visible both for PS and HS immediately 
after the interaction of Chi-C22.4%, with the SCF 
indicating a very strong stabilization and compac-
tion due to the hydrogen bond, irreversible cova-
lent formation, and electrostatic attraction (Fig. 
1F). Upon reexposure to 20 µL saliva, the COF 
again decreases, which is caused by the formation 
of a softer S-SCF by recruiting salivary glycopro-
teins (Fig. 2C). No significant difference was 
found in the relief between PS and HS after treat-
ment with either buffer (5.2 ± 1.2-fold and 4.9 ± 
1.2-fold, respectively) or Chi-C22.4% (5.1 ± 1.1-
fold and 5.0 ± 1.3-fold, respectively). The relief 
period (Fig. 3F) for Chi- C22.4% treated S-SCFs 
was drastically extended both for PS (25 ± 
4.8 min) and HS (36 ± 3.3 min) compared to 
buffer-treated SCFs, that is, PS (3.3 ± 1.3 min) 
and HS (7.2 ± 0.3 min). The longer relief period is 
attributed to Chi-C22.4%, which stabilized the SCF 
and recruited salivary glycoproteins to form a 
very soft S-SCF (Figs. 1F and 3G).
Chi-C Is Antimicrobial, and Chi-C-Treated 
S-SCF Decreases Dental Erosion and 
Remains Biocompatible
The ability of S-SCF to resist dental erosion 
increases after the modification with Chi-C, as 
shown in Figure 4. The erosion depth of enamel 
with buffer-treated (control) S-SCF was about 
125 ± 24 µm, which decreased to 83 ± 19 µm with 
Chi-C7.6% treatment, 76 ± 11 µm with Chi-C14.5%, 
and 70 ± 15 µm with Chi-C22.4% treatment. Even if 
there was no significant difference in erosion 
depths for different conjugation densities of Chi-
C, Chi-C22.4% treatment S-SCF caused a signifi-
cant drop by 44% in the erosion depth as compared 
to buffer treatment. The erosion prevention could 
be due to obstruction in citric acid diffusion 
toward the enamel or Ca2+ diffusion outward. 
Both these effects are related to an increase in the 
thickness of the S-SCF (Fig. 1) caused by Chi-C-
induced mucin recruitment and a decrease in the 
negative charge density within the S-SCF due to 
the chitosan molecule.
The safety of Chi-C use was tested on rat L292 
and human kidney epithelial cells. The result is 
shown in Figure 4C, D and Appendix Figure 7. The overview 
images on each surface clearly display more cells presented 
over culture time. After 3 d of proliferation, the SCF modified 
with Chi-C22.4% even showed a higher metabolic activity, which 
may have been caused by the S-SCF surface with a certain 
roughness (Fig. 2E and Appendix Fig. 7) or a higher softness 
(Fig. 1F). The cytotoxicity of Chi-C, tested on 2 cell lines, in 
all conjugation degrees was negligible, indicating that Chi-C is 
completely safe for biomedical applications.
Catechol conjugation of chitosan increased its antimicro-
bial efficacy on S. mutans UA159, as shown in Appendix Table 
2 and Appendix Figure 5.
Discussion
An urgent need exists to develop a new strategy to restore oral 
lubrication for xerostomia patients. Most of the current artifi-
cial saliva focuses on optimizing the viscosity, although it has 
Figure 3. Relief and relief period of the secondary salivary conditioning film (S-SCF)  
with patient saliva (PS) and healthy saliva (HS) in an ex vivo tongue-enamel friction 
system. The stimulated saliva from 4 healthy volunteers (a flow rate of 3.36, 1.76, 1.04, 
1.02 mL/min) and 4 patients with Sjögren syndrome (an etiology of xerostomia) with a 
reduced flow rate (0.48, 0.72, 0.45, 0.98 mL/min) was collected to transfer this strategy to 
a real biological tissue at macroscale. (A) Healthy S-SCF treated with buffer and  
(B) patient S-SCF treated with buffer. (C) Patient S-SCF and (D) healthy S-SCF treated 
with Chi-C22.4%, respectively. (E) Relief induced by patient and healthy S-SCF with buffer 
and Chi-C22.4% treatment. (F) Relief period of patient and healthy S-SCF with buffer 
and Chi-C22.4% treatment. (G) Schematic of Chi-C interaction with salivary mucin and 
forming a softer S-SCF. Error bar represents the standard deviation over 3 independent 
measurements. *Statistically significant (P < 0.05, 2-tailed Student’s t test) differences in 
relief period of healthy S-SCF with buffer and healthy S-SCF with Chi-C22.4% and patient 
S-SCF with Chi-C22.4% with respect to patient S-SCF with buffer. 
#Significant differences 
in relief period of healthy S-SCF with Chi-C22.4% and patient S-SCF with Chi-C22.4% with 
respect to healthy S-SCF with buffer. Chi-C, chitosan-catechol.
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been shown that there is only little correlation between viscos-
ity and ability to lubricate the oral cavity (Hahnel et al. 2009; 
Furness et al. 2011). Unlike the existing saliva substitutes, 
which overwhelm the oral cavity with exogenous molecules, 
we propose to work with the highly evolved natural salivary 
lubrication system, howsoever aberrant due to disease. Chi-C 
demonstrates the ability to stabilize SCF by the formation of a 
layered structure with a rigid lower layer due to physical and 
chemical attraction and followed by formation of the very soft 
top layer (S-SCF) in Figure 1. The ratio between dissipation 
and frequency shift (∆D3/∆f3) was larger than 10
–6, indicating 
that a hydrated, soft SCF formed on the QCM-D crystal. This 
observation is consistent with the findings of Veeregowda et al. 
(2012). The ∆D3/∆f3 for Chi-C-treated S-SCF increased irre-
spective of the conjugation degree while no obvious changes 
were found with buffer treatment. Chi-C7.6% with a low conju-
gation degree performed less efficiently in salivary protein 
recruitment than a higher conjugation degree, indicating that 
electrostatic attraction does not play a major role in salivary 
protein recruitment when Chi-C is involved. A similar phe-
nomenon was found by Kim et al. (2015), who reported that a 
higher conjugation degree of Chi-C resulted in effective 
association of Chi-C to glycoprotein. The soft top layer is 
composed of mucins recruited from the saliva, as shown by the 
increase in glycosylation (Fig. 2B) and layer softness (Fig. 1F). 
This layered structure of S-SCF decreased the friction when 
measured on a nanoscale (Fig. 2), but at macroscale (ex vivo) 
with real tissue and saliva from patients with Sjögren syn-
drome, no difference in friction (i.e., relief; Fig. 3E) was 
observed for S-SCFs with Chi-C treatment as compared to 
control. Often it is difficult to bridge the gap between macro- 
and micro/nanoscale friction (Tirrell and Meyer 2001; Ren 
et al. 2003; Stoyanov and Chromik 2017). The sliding speeds, 
applied loads, and sliding surfaces during the measurements on 
colloidal probe AFM and tongue-enamel are different, yielding 
different results.
The advantage of Chi-C treatment of S-SCF was the 
enhancement of the relief period (Fig. 3F) for both HS and PS. 
The relief period for PS was significantly lower as compares to 
HS after treatment with Chi-C. Chaudhury et al. (2015) have 
shown that although the concentration of mucins MUC5B and 
MUC7 was similar between patients with dry mouth and con-
trols, a comparison of protein and glycan staining identified a 
reduction in mucin glycosylation, especially in MUC7, for 
patients with Sjögren syndrome (Chaudhury et al. 2016). ATR-
FTIR (attenuated total reflectance Fourier-transform infrared 
Figure 4. Dental erosion prevention and safety of chitosan-catechol (Chi-C). (A) Erosion depth under different conditions by optical coherence 
tomography images. (B) The erosion depths were quantified from 3 different samples coated with secondary salivary conditioning film (S-SCF) treated 
with buffer, Chi-C7.6%, Chi-C14.5%, and Chi-C22.4%, respectively. (C) Chi-C treatment of salivary conditioning film (SCF) caused higher L929 proliferation. 
Fluorescent images of L929 cells were stained with DAPI at days 1, 3, and 7. (D) Cell metabolic activity measured by XTT. Statistical differences are 
marked by *P < 0.05.
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spectroscopy) measurements (Song et al. 2016) on the saliva 
used in our study (Appendix Fig. 4) confirmed lower glycosyl-
ation in the 4 PS samples as compared to HS. Chi-C is able to 
recruit mucins from PS on the SCF, but due to lower glycosyl-
ation, the S-SCF still has lower water-holding ability, which 
results in a lower relief period.
Based on the result from the tongue-enamel friction system, 
where the total amount of fluid is the same but the relief period 
is different, the surface-bound molecules take precedence in 
lubrication, that is, attracting mucin on SCF yields a long-lasting 
relief period. Treatment with Chi-C gives rise to a softer (Fig. 
1F) and thicker (Fig. 1E) top layer, which is able to hold the 
water for a longer period of time and hence the long relief 
period. A similar mechanism was found by Singh et al. (2014), 
in which hyaluronan binding peptides were able to restore the 
lubrication of degraded cartilage. Besides lubrication, the pres-
ence of SCFs is essential to reduce dental erosion (Busscher 
et al. 2007; Santos et al. 2010). Our results (Fig. 4A, B) show 
that the layered S-SCFs formed due to Chi-C treatment decrease 
dental erosion. Yet another problem of xerostomia patients is 
the high risk of developing oral infections. Chitosan is known 
for its broad-spectrum antibiotic activity, but this activity is lim-
ited due to its low solubility at neutral pH. Conjugation with 
catechol enhances chitosan solubility (Kim et al. 2013) and 
causes a 4-fold reduction in its minimal inhibitory concentra-
tion (MIC) for Staphylococcus epidermidis (Amato et al. 2018). 
We tested the antibacterial activity of Chi-C on the more rele-
vant S. mutans UA159. Both the MIC (0.5 mg/mL) and the 
minimal bactericidal concentration (MBC) (1 mg/mL) for S. 
mutans were reduced with Chi-C compared to the Chi with a 
higher MIC (1 mg/mL) and MBC (2 mg/mL) (Appendix Table 2 
and Appendix Fig. 5). The promising ex vivo results obtained 
for the use of Chi-C indicate that this molecule is a strong can-
didate for human trials.
In summary, the strategy to work together with an impaired 
but highly evolved natural lubrication system is promising. A 
simple mucoadhesive, Chi-C, is able to bind to the SCF and 
recruit mucins from the saliva by both physisorption and chemi-
sorption to form a nanocomposite S-SCF (rigid bottom and soft 
top) to enhance oral lubrication. These structural and composi-
tional adjustments in the S-SCF extend the relief period at the 
macroscale with saliva from patients with Sjögren syndrome and 
decrease dental erosion. Thus, Chi-C22.4% is a strong candidate 
molecule as an additive to future artificial saliva formulations.
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